Posted in | News | Lithium | Rare Earth Elements

First Gold Exploration Report Latest Drilling Results from Lac Pivert-Rose Project

First Gold Exploration Inc. (TSX VENTURE:EFG) (OTCQX:FGEXF) (FRANKFURT:F12) has reported the latest drill results for the Lac Pivert/Rose project.

Twelve holes numbered JR-10-01 to JR-10-12 were drilled on this showing. All the holes intersected the mineralized zone. The results are significant because they are very similar to the initial results of early drilling on the Rose showing.

"This is a very important discovery for the Company, because this showing also lies on surface, and could therefore lead to a higher lithium-tantalum-beryllium-gallium-rubidium resource at the Pivert/Rose project relatively quickly and inexpensively," said Jean-Sébastien Lavallée, Interim President and Chief Executive Officer.

The best results obtained to date are as follows:

All the samples were sent for analysis in sealed containers to the Chemex laboratory in Val-d'Or by employees of the Company. Chemex is the laboratory used for analysis of all samples from programs on the Lac Pivert/Rose property. The samples are weighed and identified prior to sample preparation. The samples are crushed to 70% minus 2 mm, then separated and pulverized to 85% passing 75 µm. All samples are analyzed using ICP-MS, with full analysis for 47 elements.

Jean-Sebastien Lavallee (OGQ #773), geologist, shareholder and interim president and chief executive officer of the Company and a Qualified Person under NI 43-101, has reviewed and approved the technical content of this release.

Source:

First Gold Exploration Inc.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.